301246 宏源藥業
按盤價 
14.500 -0.180 (-1.226%)
14.500 -0.180 (-1.226%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.830 | 2.693 | 22.933 | 34.508 | 24.362 |
| 總資產報酬率 ROA (%) | 0.628 | 1.830 | 13.786 | 23.607 | 14.554 |
| 投入資產回報率 ROIC (%) | 0.711 | 2.144 | 17.436 | 29.964 | 19.244 | 邊際利潤分析 |
| 銷售毛利率 (%) | 12.539 | 12.987 | 23.324 | 33.635 | 38.444 |
| 營業利潤率 (%) | 3.455 | 5.141 | 23.256 | 34.758 | 24.885 |
| 息稅前利潤/營業總收入 (%) | 3.390 | 4.631 | 22.630 | 34.808 | 25.032 |
| 淨利潤/營業總收入 (%) | 2.733 | 4.242 | 21.069 | 31.299 | 19.739 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 124.529 | 90.912 | 66.078 | 65.527 | 107.935 |
| 價值變動淨收益/利潤總額(%) | 4.397 | 22.606 | 35.567 | 34.909 | -4.826 |
| 營業外收支淨額/利潤總額(%) | -0.689 | -7.190 | -0.410 | -0.622 | -6.090 | 償債能力分析 |
| 流動比率 (X) | 2.559 | 3.500 | 1.261 | 1.667 | 1.874 |
| 速動比率 (X) | 2.357 | 3.291 | 0.994 | 1.044 | 1.190 |
| 資產負債率 (%) | 25.779 | 22.845 | 45.453 | 31.011 | 32.393 |
| 帶息債務/全部投入資本 (%) | 13.147 | 11.754 | 28.092 | 7.396 | 9.960 |
| 股東權益/帶息債務 (%) | 646.743 | 733.974 | 244.423 | 1,188.820 | 856.758 |
| 股東權益/負債合計 (%) | 287.910 | 337.728 | 120.007 | 222.464 | 208.712 |
| 利息保障倍數 (X) | -81.922 | -28.042 | -42.601 | 131.159 | 15.892 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 48.277 | 45.928 | 39.143 | 27.248 | 27.299 |
| 存貨周轉天數 (天) | 50.213 | 54.810 | 83.884 | 125.130 | 141.735 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
